SCHEMBL3694723

SCHEMBL3694723

Cn1nc(C(=O)O)c2ccc([N+](=O)[O-])cc21

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ L3MBTL1 Q9Y468 1/20 0.51
▸ ELANE P08246 3/20 0.46
▸ F2 P00734 2/20 0.46
▸ PLAU P00749 2/20 0.46
▸ CTRB1 P17538 2/20 0.46
▸ KLKB1 P03952 1/20 0.44
▸ ALDH1A1 P00352 4/20 0.44
▸ TDP1 Q9NUW8 2/20 0.44
▸ CYP3A4 P08684 1/20 0.44
▸ ALOX15 P16050 1/20 0.44
▸ CNR2 P34972 1/20 0.44
▸ MEN1 O00255 1/20 0.42
▸ POLB P06746 1/20 0.42
▸ PKM P14618 1/20 0.42
▸ NPY1R P25929 1/20 0.42
▸ NPY2R P49146 1/20 0.42
▸ KMT2A Q03164 1/20 0.42
▸ LMNA P02545 1/20 0.41
▸ CYP1A2 P05177 1/20 0.41
▸ MAPT P10636 5/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2851292 1.00 L3MBTL1 (0.51) L3MBTL1ELANEF2PLAUCTRB1
SCHEMBL13854989 0.89 L3MBTL1 (0.61) L3MBTL1ELANEF2PLAUCTRB1
SCHEMBL2848565 0.86 ELANE (0.61) L3MBTL1ELANEF2PLAUCTRB1
SCHEMBL2845665 0.85 ELANE (0.47) L3MBTL1ELANEF2PLAUCTRB1
SCHEMBL31554629 0.84 L3MBTL1 (0.47) L3MBTL1ELANEF2PLAUCTRB1
SCHEMBL11153081 0.82 L3MBTL1 (0.45) L3MBTL1ELANEF2PLAUCTRB1
SCHEMBL2843483 0.82 MAPT (0.51) L3MBTL1ELANEF2PLAUCTRB1
SCHEMBL14909376 0.81 L3MBTL1 (0.51) L3MBTL1ELANEF2PLAUCTRB1
SCHEMBL3380500 0.79 L3MBTL1 (0.52) L3MBTL1ELANEF2PLAUCTRB1
SCHEMBL31554652 0.79 L3MBTL1 (0.47) L3MBTL1ELANEF2PLAUCTRB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2185572-A1 SUBSTITUTED ARYLSULFONYLAMINOMETHYLPHOSPHONIC ACID DERIVATIVES, THEIR PREPARATION AND THEIR USE IN THE TREATMENT OF TYPE I AND II DIABETES MELLITUS Boehringer Ingelheim International GmbH (DE) 2010-05-19 — — EP disclosed
WO-2009016119-A1 SUBSTITUTED ARYLSULFONYLAMINOMETHYLPHOSPHONIC ACID DERIVATIVES, THEIR PREPARATION AND THEIR USE IN THE TREATMENT OF TYPE I AND II DIABETES MELLITUS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2009-02-05 — — WO disclosed
Send feedback